Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Ophthalmology. 2020 Mar 29;127(9):1201–1210. doi: 10.1016/j.ophtha.2020.03.021

Figure 3.

Figure 3.

Mean change in visual acuity over time for all eyes (A) and stratified by baseline visual acuity of 68 to 24 letters (approximate Snellen equivalent 20/50 to 20/320) (B) and 78 to 69 letters (approximal Snellen equivalent 20/32 to 20/40) (C) among follow-up study participants from a 2-year clinical trial on anti-vascular endothelial growth factor treatment for eyes with diabetic macular edema (Protocol T). Change in visual acuity was truncated to the mean ± 3 standard deviations of the change from baseline to 5 years (7.12 ± 3 × 16.04). Eyes missing visual acuity at the 5-year visit were excluded.